HuR/Cx40 downregulation causes coronary microvascular dysfunction in type 2 diabetesRui Si, Ayako Makino, Jian‐Ying Wang et al.|JCI Insight|2021Cited by 23
eNAMPT is a novel therapeutic target for mitigation of coronary microvascular disease in type 2 diabetesLei Gao, Ayako Makino, Francisco J. Ramírez et al.|Diabetologia|2024Cited by 6
Pathophysiological role of NAMPT in endothelial functionFrancisco Ramirez, Ayako Makino, Jody Tori O. Cabrera et al.|Physiology|2023Cited by 1
Abstract 14365: Identification of MicroRNAs and Their Target Genes in Microvascular Disease in DiabetesLei Gao, Ayako Makino, Atsumi Tsuji Hosokawa et al.|Circulation|2020Cited by 0
Sex differences in the development of coronary microvascular diseases in type-2 diabetes: possible role of gap junction protein connexin-40Md Rahatullah Razan, Ayako Makino, Rui Si et al.|Physiology|2023Cited by 0